Biogen Inc (NASDAQ: BIIB)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 01/17/2020
Closing price: 285.50
|Support price level:||$270.83|
|Resistance price level:||$302.25|
|Relative strength index (14-day RSI)||31.3|
- With a -15.6 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- BIIB is one of this month's worst performers with a return of -3.7%, underperforming 90 percent of stocks in the S&P-100.
- Down 3.7 percent, BIIB is one of this week's biggest decliners.
- BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 40.0%.
- Volatility is forecast to fall over the next month.
- BIIB is above its 200-day moving average, providing a measure of support for long positions.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 10.9% in the next week.
- 21.3% in the next month.
- 84.4% in the next year.